Hydrocortisone / Pramoxine Topical Dosage

Medically reviewed by Drugs.com. Last updated on Aug 8, 2023.

Usual Adult Dose for Dermatitis

Apply as a thin film to the affected area 3 to 4 times daily

Usual Adult Dose for Psoriasis

Apply as a thin film to the affected area 3 to 4 times daily

Usual Adult Dose for Hemorrhoids

Apply as a thin film to the affected area 3 to 4 times daily

Usual Pediatric Dose for Dermatitis

Apply as a thin film to the affected area 3 to 4 times daily

Comments:

• Pediatric patients are more susceptible to systemic toxicity due to proportionally greater absorption from a greater skin surface area to body weight ratio.
• Reversible hypothalamic-pituitary-adrenal (HPA) axis suppression, Cushing's syndrome manifestations, and intracranial hypertension have been reported in pediatric patients after systemic absorption of topically applied corticosteroids.
• Pediatric manifestations of adrenal suppression include linear growth hindrance, weight gain delayed, low plasma cortisol, and lack of response to ACTH stimulation.
• Limit use to the least amount compatible with effective therapy.

Usual Pediatric Dose for Psoriasis

Apply as a thin film to the affected area 3 to 4 times daily

Comments:

• Pediatric patients are more susceptible to systemic toxicity due to proportionally greater absorption from a greater skin surface area to body weight ratio.
• Reversible hypothalamic-pituitary-adrenal (HPA) axis suppression, Cushing's syndrome manifestations, and intracranial hypertension have been reported in pediatric patients after systemic absorption of topically applied corticosteroids.
• Pediatric manifestations of adrenal suppression include linear growth hindrance, weight gain delayed, low plasma cortisol, and lack of response to ACTH stimulation.
• Limit use to the least amount compatible with effective therapy.

Usual Pediatric Dose for Hemorrhoids

Apply as a thin film to the affected area 3 to 4 times daily

Comments:

• Pediatric patients are more susceptible to systemic toxicity due to proportionally greater absorption from a greater skin surface area to body weight ratio.
• Reversible hypothalamic-pituitary-adrenal (HPA) axis suppression, Cushing's syndrome manifestations, and intracranial hypertension have been reported in pediatric patients after systemic absorption of topically applied corticosteroids.
• Pediatric manifestations of adrenal suppression include linear growth hindrance, weight gain delayed, low plasma cortisol, and lack of response to ACTH stimulation.
• Limit use to the least amount compatible with effective therapy.

Renal Dose Adjustments

Data not available

Liver Dose Adjustments

Data not available

Precautions

CONTRAINDICATIONS:

• Hypersensitivity to any of the ingredients

Consult WARNINGS section for additional precautions.

Dialysis

Data not available

Other Comments

Administration advice:

• Aerosol foam: Use supplied applicator for anal administration; transfer a small amount to a tissue and rub in gently for perianal use.
• Aerosol foam: Do not insert any part of the aerosol canister directly into the anus.

See also:

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Medical Disclaimer